CN104116744A - 治疗抑郁症的药物组合物 - Google Patents
治疗抑郁症的药物组合物 Download PDFInfo
- Publication number
- CN104116744A CN104116744A CN201410389677.9A CN201410389677A CN104116744A CN 104116744 A CN104116744 A CN 104116744A CN 201410389677 A CN201410389677 A CN 201410389677A CN 104116744 A CN104116744 A CN 104116744A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- arginine
- methopterin
- effect
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410389677.9A CN104116744A (zh) | 2014-08-08 | 2014-08-08 | 治疗抑郁症的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410389677.9A CN104116744A (zh) | 2014-08-08 | 2014-08-08 | 治疗抑郁症的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104116744A true CN104116744A (zh) | 2014-10-29 |
Family
ID=51762525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410389677.9A Pending CN104116744A (zh) | 2014-08-08 | 2014-08-08 | 治疗抑郁症的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104116744A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106135895A (zh) * | 2015-04-21 | 2016-11-23 | 淄博维克勋医药技术有限公司 | 一种营养补充剂 |
CN114917213A (zh) * | 2022-07-05 | 2022-08-19 | 湖南洞庭药业股份有限公司 | 包含阿米替林的精神疾病治疗剂和治疗精神疾病的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813656A (zh) * | 2012-09-13 | 2012-12-12 | 广东岭南制药有限公司 | 5-甲基四氢叶酸或其盐的稳定药物组合物 |
-
2014
- 2014-08-08 CN CN201410389677.9A patent/CN104116744A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813656A (zh) * | 2012-09-13 | 2012-12-12 | 广东岭南制药有限公司 | 5-甲基四氢叶酸或其盐的稳定药物组合物 |
Non-Patent Citations (5)
Title |
---|
RICHARD C. SHELTON 等: "Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial", 《PRIMARY CARE COMPANION TO CNS DISORDERS》 * |
STN: "RN 134-35-0", 《REGISTRY》 * |
奚耕思等: "抑郁症发生机制研究进展", 《陕西师范大学学报(自然科学版)》 * |
张广芬等: "L-精氨酸/一氧化氮信号通路氯胺酮抗抑郁中的作用", 《中华行为医学与脑科学杂志》 * |
汪春运: "叶酸治疗抑郁症", 《四川精神卫生》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106135895A (zh) * | 2015-04-21 | 2016-11-23 | 淄博维克勋医药技术有限公司 | 一种营养补充剂 |
CN114917213A (zh) * | 2022-07-05 | 2022-08-19 | 湖南洞庭药业股份有限公司 | 包含阿米替林的精神疾病治疗剂和治疗精神疾病的方法 |
CN114917213B (zh) * | 2022-07-05 | 2023-11-21 | 湖南洞庭药业股份有限公司 | 包含阿米替林的精神疾病治疗剂和治疗精神疾病的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meltzer et al. | A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. | |
TW200403997A (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
CN104758307A (zh) | Nadh和nmn在制备帕金森病药物或保健品的应用 | |
CN106858608A (zh) | 一种有益于抑郁症患者健康的营养组合物 | |
EP3395341A1 (en) | Composition for treating motor neuron diseases and use thereof | |
CN104116744A (zh) | 治疗抑郁症的药物组合物 | |
CN104435100B (zh) | 一种抗抑郁组合物 | |
LU500641B1 (en) | A pharmaceutical composition for treating depression | |
CN102823862A (zh) | 一种用于气虚体质的组合物及其制备方法和用途 | |
CN103027926A (zh) | 一种用于营养补充剂的药物组合物及其口服液制备方法 | |
CN106902124A (zh) | 齐墩果酸类衍生物的应用 | |
CN104138389A (zh) | 治疗血液循环障碍类疾病的药物组合物 | |
CN101474185A (zh) | 一种抗心脑血管疾病的西药复方制剂及其制备方法 | |
Sladkova et al. | Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry. Introduction | |
CN101780099B (zh) | 环磷腺苷葡胺组合药物 | |
CN101156842A (zh) | 含精氨酸谷氨酸的药物制剂 | |
CN111838669B (zh) | 治疗改善易损脏器的纳米组合物、制剂及制备方法和用途 | |
CN103720666A (zh) | 一种注射用硼替佐米冻干制剂的制备方法 | |
US11331319B2 (en) | Combination treatment for neuropsychiatric disorders | |
JP7440730B2 (ja) | 医薬組成物及び抗骨粗鬆症薬の調製における応用 | |
US20150342985A1 (en) | Compositions comprising lithium | |
Sazeli et al. | Apoptosis Event in Hela Cells Treated with Cisplatin, Gallic Acid and Combination of Both | |
CN110279665A (zh) | 一种含有头孢呋辛酯的组合药片 | |
CN102114066B (zh) | 一种缓解体力疲劳的药物组合物 | |
WO2011119126A1 (ru) | Применение щавелевой кислоты в производстве лечебного препарата противоопухолевого действия по отношению к злокачественным клеткам, лечебный препарат на его основе и способ лечения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Ping Inventor after: Li Chenxi Inventor after: Wu Sai Inventor before: Li Ping |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170515 Address after: 255000, No. 12, building 701, East Garden, Nanjing Road, Zhangdian District, Shandong, Zibo Applicant after: Li Jian Address before: 1608, room 1, research building of bio pharmaceutical industry innovation park, No. 255086, Tai Mo Road, hi tech Zone, Shandong, Zibo Applicant before: ZIBO WEIKEXUN MEDICAL TECHNOLOGY CO., LTD. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141029 |